Article

Promotion of an Antitumor Immune Program by a Tumor Specific Complement Activating Autoantibody

2023-10-18

Abstract excerpt

<title>Abstract</title> <p>Tumor targeting antibodies can be used to initiate an antitumor immune program, which appears essential to achieve a long-term durable clinical response to cancer. We previously identified an anti-complement factor H (CFH) autoantibody associated with early-stage non-small cell lung cancer (NSCLC) patients, and from their peripheral B cells cloned a monoclonal antibody, GT103, that spec...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f2913a5a-7a85-574e-ac0f-2ba31f197f9e
DOI: 10.21203/rs.3.rs-2001920/v3

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Promotion of an Antitumor Immune Program by a Tumor Specific Complement Activating AutoantibodyDOI 10.21203/rs.3.rs-2001920/v3Read

Local, but not circulating, complement C3 governs immune checkpoint blockade efficacySemantic proximity Read

Complement as a Biological Tool to Control Tumor GrowthSemantic proximity Read

The complement system as a target in cancer immunotherapySemantic proximity Read

Interplay between the complement system and other immune pathways in the tumor microenvironmentSemantic proximity Read

Reimagining antibody-dependent cellular cytotoxicity in cancer: the potential of natural killer cell engagersSemantic proximity Read

Monoclonal Antibodies against Epidermal Growth Factor Receptor Acquire an Ability To Kill Tumor Cells through Complement Activation by Mutations That Selectively Facilitate the Hexamerization of IgG on Opsonized Cells.Semantic proximity Read

Complement C3d enables protective immunity capable of distinguishing spontaneously transformed from non-transformed cellsSemantic proximity Read

A Novel Platform for the Potentiation of Therapeutic Antibodies Based on Antigen-Dependent Formation of IgG Hexamers at the Cell Surface.Semantic proximity Read

A germline variant of human IgG1+ B cell receptor represses colorectal tumorigenesis and progression by shaping the tumor microenvironmentSemantic proximity Read

Regulation of complement and modulation of its activity in monoclonal antibody therapy of cancerSemantic proximity Read

Agnostic B cell selection approach identifies antibodies against K. pneumoniae that synergistically drive complement activation.Semantic proximity Read

Chitinase 3-like-1 (CHI3L1) in the Pathogenesis of Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung CancerSemantic proximity Read